UABT

Serial Number 90511057
Registration 7422434
700

Registration Progress

Application Filed
Feb 4, 2021
Under Examination
Oct 19, 2021
Approved for Publication
Aug 24, 2021
Published for Opposition
Aug 24, 2021
Registered
Jun 18, 2024

Trademark Image

UABT

Basic Information

Serial Number
90511057
Registration Number
7422434
Filing Date
February 4, 2021
Registration Date
June 18, 2024
Published for Opposition
August 24, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
001

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
Ritter House, P.O. Box 173
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
New Haven, CT

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Biohaven Therapeutics Ltd.

Original Registrant
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
1780 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 10, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 10, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 23, 2024 ALIE A ASSIGNED TO LIE Loading...
Apr 23, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 4, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 1, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 1, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 1, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Nov 1, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 1, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 19, 2023 IUAF S USE AMENDMENT FILED Loading...
Oct 19, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 5, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 17, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 15, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 15, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 24, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 24, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 4, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 20, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 20, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 20, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 20, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 20, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 8, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biomedical binding compounds for laboratory and research use in the pharmaceutical and medical fields, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals
First Use Anywhere: Mar 7, 2023
First Use in Commerce: Mar 7, 2023

Classification

International Classes
001